Concepedia

Natàlia Reixach

NR

Statistics

Publications

28

Citations

2.4K

H-Index

23

Active since

1994

Affiliations

Scripps Research Institute(Current)

Centro de Investigación y Desarrollo

University of California San Diego

University of the Pacific

Stanford University

Natàlia Reixach is an author at Scripps Research Institute specializing in medicine, natural sciences, and pharmacology.

ORCID

Top concepts

Publications per year

1994–2017

28

Publications

28

Tissue damage in the amyloidoses: Transthyretin monomers and nonnative oligomers are the major cytotoxic species in tissue culture

Natàlia Reixach, Songpon Deechongkit, Xin Jiang et al. · Proceedings of the National Academy of Sciences · 2004 · 381 citations · Full text

Transthyretin protects Alzheimer's mice from the behavioral and biochemical effects of Aβ toxicity

Joel N. Buxbaum, Zhengyi Ye, Natàlia Reixach et al. · Proceedings of the National Academy of Sciences · 2008 · 284 citations · Full text

AG10 inhibits amyloidogenesis and cellular toxicity of the familial amyloid cardiomyopathy-associated V122I transthyretin

Sravan Penchala, Stephen Connelly, Yu Wang et al. · Proceedings of the National Academy of Sciences · 2013 · 184 citations · Full text

, , +13

Repositioning tolcapone as a potent inhibitor of transthyretin amyloidogenesis and associated cellular toxicity

Ricardo Sant’Anna, Pablo Gallego, Lei Z. Robinson et al. · Nature Communications · 2016 · 178 citations · Full text

Neuronal Production of Transthyretin in Human and Murine Alzheimer's Disease: Is It Protective?

Xinyi Li, Eliezer Masliah, Natàlia Reixach et al. · Journal of Neuroscience · 2011 · 146 citations · Full text

Rows per page

1–5 of 28